Sharan Kimberly Rai, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gout | 18 | 2024 | 557 | 3.030 |
Why?
|
Diet, Vegetarian | 1 | 2024 | 180 | 0.830 |
Why?
|
Gout Suppressants | 6 | 2019 | 167 | 0.680 |
Why?
|
Diet, Mediterranean | 2 | 2023 | 718 | 0.660 |
Why?
|
Allopurinol | 5 | 2019 | 186 | 0.580 |
Why?
|
Cost of Illness | 2 | 2017 | 1878 | 0.540 |
Why?
|
Polymyositis | 1 | 2015 | 75 | 0.510 |
Why?
|
Dermatomyositis | 1 | 2015 | 248 | 0.420 |
Why?
|
Hyperuricemia | 3 | 2019 | 205 | 0.370 |
Why?
|
Hospital Costs | 1 | 2017 | 958 | 0.370 |
Why?
|
Lupus Erythematosus, Systemic | 4 | 2018 | 2103 | 0.350 |
Why?
|
Arthritis, Rheumatoid | 6 | 2018 | 3734 | 0.350 |
Why?
|
Cause of Death | 4 | 2017 | 3615 | 0.350 |
Why?
|
Diet, Carbohydrate-Restricted | 2 | 2023 | 259 | 0.330 |
Why?
|
Uric Acid | 5 | 2021 | 738 | 0.320 |
Why?
|
British Columbia | 3 | 2019 | 240 | 0.320 |
Why?
|
Disability Evaluation | 1 | 2015 | 1808 | 0.300 |
Why?
|
Atherosclerosis | 1 | 2023 | 3417 | 0.290 |
Why?
|
Drug Eruptions | 2 | 2019 | 317 | 0.260 |
Why?
|
Rheumatic Diseases | 3 | 2018 | 622 | 0.260 |
Why?
|
Hospitalization | 5 | 2019 | 10329 | 0.240 |
Why?
|
Hypertension | 4 | 2021 | 8358 | 0.230 |
Why?
|
Antirheumatic Agents | 4 | 2018 | 1351 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2018 | 3269 | 0.200 |
Why?
|
Health Care Costs | 1 | 2015 | 3186 | 0.200 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15537 | 0.190 |
Why?
|
Incidence | 7 | 2024 | 20812 | 0.190 |
Why?
|
Uricosuric Agents | 2 | 2019 | 26 | 0.180 |
Why?
|
Probenecid | 2 | 2019 | 73 | 0.180 |
Why?
|
Diuretics | 2 | 2020 | 581 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11940 | 0.160 |
Why?
|
Health Occupations | 1 | 2020 | 220 | 0.160 |
Why?
|
Obesity | 5 | 2023 | 12670 | 0.160 |
Why?
|
Diet, Fat-Restricted | 1 | 2020 | 326 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2018 | 12273 | 0.150 |
Why?
|
Middle Aged | 24 | 2024 | 214412 | 0.140 |
Why?
|
Sulfinpyrazone | 1 | 2016 | 15 | 0.140 |
Why?
|
Population Growth | 1 | 2016 | 49 | 0.140 |
Why?
|
Aged | 20 | 2024 | 164236 | 0.130 |
Why?
|
Spondylitis, Ankylosing | 1 | 2017 | 154 | 0.130 |
Why?
|
Poisson Distribution | 1 | 2017 | 506 | 0.130 |
Why?
|
Colchicine | 1 | 2016 | 254 | 0.120 |
Why?
|
Comorbidity | 4 | 2016 | 10351 | 0.120 |
Why?
|
Male | 25 | 2024 | 351093 | 0.120 |
Why?
|
Hydroxychloroquine | 1 | 2018 | 419 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11655 | 0.120 |
Why?
|
Adiposity | 1 | 2023 | 1822 | 0.110 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2016 | 235 | 0.110 |
Why?
|
Stroke | 1 | 2015 | 9693 | 0.110 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2016 | 334 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.110 |
Why?
|
Medication Adherence | 2 | 2015 | 2113 | 0.110 |
Why?
|
Diet Surveys | 1 | 2017 | 1150 | 0.110 |
Why?
|
Risk Factors | 8 | 2024 | 72416 | 0.100 |
Why?
|
Alcohol Drinking | 3 | 2020 | 3960 | 0.100 |
Why?
|
Humans | 33 | 2024 | 746044 | 0.100 |
Why?
|
Female | 24 | 2024 | 382109 | 0.100 |
Why?
|
Ophthalmology | 1 | 2018 | 514 | 0.100 |
Why?
|
Databases, Factual | 8 | 2018 | 7810 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2016 | 776 | 0.100 |
Why?
|
Cohort Studies | 10 | 2020 | 40503 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2023 | 38752 | 0.090 |
Why?
|
Prospective Studies | 4 | 2024 | 53218 | 0.090 |
Why?
|
Adult | 13 | 2024 | 214958 | 0.080 |
Why?
|
Cardiovascular Diseases | 4 | 2020 | 15308 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12018 | 0.080 |
Why?
|
Myocardial Ischemia | 1 | 2019 | 2142 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9520 | 0.080 |
Why?
|
Pilot Projects | 1 | 2021 | 8370 | 0.070 |
Why?
|
Disease Management | 1 | 2018 | 2451 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5821 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2117 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2244 | 0.070 |
Why?
|
Prevalence | 3 | 2019 | 15308 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2193 | 0.070 |
Why?
|
Survival Rate | 2 | 2017 | 12632 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25177 | 0.060 |
Why?
|
United States | 6 | 2024 | 70383 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14113 | 0.060 |
Why?
|
Health Personnel | 1 | 2017 | 3215 | 0.060 |
Why?
|
Survival Analysis | 1 | 2015 | 10127 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1659 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5458 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2891 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3072 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 387 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7271 | 0.050 |
Why?
|
Body Mass Index | 4 | 2020 | 12633 | 0.050 |
Why?
|
Depression | 1 | 2020 | 7826 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1848 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29068 | 0.040 |
Why?
|
Israel | 1 | 2020 | 707 | 0.040 |
Why?
|
Drug Dosage Calculations | 1 | 2018 | 115 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5764 | 0.040 |
Why?
|
Risk Assessment | 2 | 2016 | 23453 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2020 | 481 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 10718 | 0.030 |
Why?
|
Mortality | 2 | 2018 | 2852 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11089 | 0.030 |
Why?
|
Fruit | 1 | 2021 | 1150 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1188 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2011 | 0.030 |
Why?
|
Eating | 1 | 2021 | 1531 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2015 | 8304 | 0.030 |
Why?
|
Weight Gain | 1 | 2023 | 2310 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 63661 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1094 | 0.030 |
Why?
|
Retinal Diseases | 1 | 2018 | 689 | 0.030 |
Why?
|
Reminder Systems | 1 | 2015 | 373 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2258 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2842 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2017 | 78297 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3589 | 0.020 |
Why?
|
Life Style | 1 | 2020 | 3820 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2636 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2677 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57557 | 0.020 |
Why?
|
Overweight | 1 | 2019 | 2385 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 57106 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4590 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2015 | 1047 | 0.020 |
Why?
|
Insulin Resistance | 1 | 2020 | 3836 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10279 | 0.020 |
Why?
|
Mental Health | 1 | 2020 | 3091 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2190 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4401 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2278 | 0.020 |
Why?
|
Logistic Models | 1 | 2018 | 13164 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18146 | 0.010 |
Why?
|
Diet | 1 | 2019 | 7881 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6056 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21673 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 8975 | 0.010 |
Why?
|
Pregnancy | 1 | 2016 | 29294 | 0.010 |
Why?
|
Animals | 1 | 2023 | 166331 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 86202 | 0.010 |
Why?
|